ExploreWatchlistsPricing
  1. JP-listed companies
  2. Fuji Pharma Co.,Ltd.
  3. Financials
  4. Stockholders' equity

Fuji Pharma Co.,Ltd. (4554)

Market cap
¥61.9B
P/E ratio
27.2x
Develops and manufactures specialized injectable medications for hospitals and medical distributors, focusing on hormone treatments and medical imaging contrast agents.
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndStockholders' equity (Million JPY)YoY (%)
Sep 30, 202546,908+2.95%
Sep 30, 202445,563+10.65%
Sep 30, 202341,177+15.00%
Sep 30, 202235,806+9.56%
Sep 30, 202132,681-18.22%
Sep 30, 202039,961+1.52%
Sep 30, 201939,363+11.35%
Sep 30, 201835,350+8.43%
Sep 30, 201732,601+11.55%
Sep 30, 201629,226+2.21%
Sep 30, 201528,593+0.17%
Sep 30, 201428,544+18.61%
Sep 30, 201324,066

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat